These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21084495)

  • 1. Characterization of antibody-mediated neutralization directed against the hypervariable region 1 of hepatitis C virus E2 glycoprotein.
    Vieyres G; Dubuisson J; Patel AH
    J Gen Virol; 2011 Mar; 92(Pt 3):494-506. PubMed ID: 21084495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization.
    Prentoe J; Jensen TB; Meuleman P; Serre SB; Scheel TK; Leroux-Roels G; Gottwein JM; Bukh J
    J Virol; 2011 Mar; 85(5):2224-34. PubMed ID: 21123377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproduction in vitro of a quasispecies from a hepatitis C virus-infected patient and determination of factors that influence selection of a dominant species.
    Kawaguchi K; Faulk K; Purcell RH; Emerson SU
    J Virol; 2011 Apr; 85(7):3408-14. PubMed ID: 21270157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype.
    Tarr AW; Urbanowicz RA; Hamed MR; Albecka A; McClure CP; Brown RJ; Irving WL; Dubuisson J; Ball JK
    J Virol; 2011 May; 85(9):4246-57. PubMed ID: 21325403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.
    Reuter N; Kropff B; Schneiderbanger JK; Alt M; Krawczyk A; Sinzger C; Winkler TH; Britt WJ; Mach M; Thomas M
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.
    Giang E; Dorner M; Prentoe JC; Dreux M; Evans MJ; Bukh J; Rice CM; Ploss A; Burton DR; Law M
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6205-10. PubMed ID: 22492964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus.
    Thomas A; Thiono DJ; Kudlacek ST; Forsberg J; Premkumar L; Tian S; Kuhlman B; de Silva AM; Metz SW
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32611757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A broadly neutralizing human monoclonal antibody generated from transgenic mice immunized with HCMV particles limits virus infection and proliferation.
    Atanasoff KE; Parsons AJ; Ophir SI; Lurain N; Kraus T; Moran T; Duty JA; Tortorella D
    J Virol; 2024 Jul; 98(7):e0021324. PubMed ID: 38832789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of KSHV vaccine platforms and chimeric MHV68-K-K8.1 glycoprotein for evaluating the
    Yang W-S; Kim D; Kang S; Lai C-J; Cha I; Chang P-C; Jung JU
    mBio; 2024 Dec; 15(12):e0291324. PubMed ID: 39475238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies.
    Niespodziana K; Cabauatan CR; Pazderova P; Vacal PC; Wortmann J; Keller W; Errhalt P; Valenta R
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of new functional regions in hepatitis C virus envelope glycoprotein E2.
    Albecka A; Montserret R; Krey T; Tarr AW; Diesis E; Ball JK; Descamps V; Duverlie G; Rey F; Penin F; Dubuisson J
    J Virol; 2011 Feb; 85(4):1777-92. PubMed ID: 21147916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Far Posterior Approach for Rib Fracture Fixation: Surgical Technique and Tips.
    Manes TJ; DeGenova DT; Taylor BC; Patel JN
    JBJS Essent Surg Tech; 2024; 14(4):. PubMed ID: 39650795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes.
    Oguntuyo KY; Haas GD; Azarm KD; Stevens CS; Brambilla L; Kowdle SS; Avanzato VA; Pryce R; Freiberg AN; Bowden TA; Lee B
    J Virol; 2024 Mar; 98(3):e0183823. PubMed ID: 38426726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity.
    Richardson SI; Mzindle N; Motlou T; Manamela NP; van der Mescht MA; Lambson BE; Everatt J; Amoako DG; Balla S; von Gottberg A; Wolter N; de Beer Z; de Villiers TR; Bodenstein A; van den Berg G; Abdullah F; Rossouw TM; Boswell MT; Ueckermann V; Bhiman JN; Moore PL
    J Virol; 2024 Jul; 98(7):e0067824. PubMed ID: 38953380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and epitope mapping of novel neutralizing monoclonal antibodies against glycoprotein E2 of CSFV.
    Mi S; Bao F; Liu Z; Zhang Y; Li H; Wu M; Tu C; Gong W
    Int J Biol Macromol; 2024 Dec; 282(Pt 1):136609. PubMed ID: 39414201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.
    Benhnia MR; McCausland MM; Su HP; Singh K; Hoffmann J; Davies DH; Felgner PL; Head S; Sette A; Garboczi DN; Crotty S
    J Virol; 2008 Apr; 82(7):3751-68. PubMed ID: 18234801
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.